Significantly high institutional ownership implies Viking Therapeutics' stock price is sensitive to their trading actions. A total of 9 investors have a majority stake in the company with 51% ...Viking Therapeutics (VKTX) Stock Price, News & Analysis $36.20 +4.35 (+13.66%) (As of 02/16/2024 08:54 PM ET) Compare Today's Range $31.58 $37.22 50 …Viking Therapeutics, Inc. Common Stock (VKTX) ... and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial performance ...Find the latest Viking Therapeutics, Inc. (1VT.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Price target. 37.56R USD +5.71 +17.91%. The 9 analysts offering 1 year price forecasts for Viking Therapeutics, Inc. have a max estimate of 50.00 and a min estimate of 28.00.Viking Thera (VKTX) Company Description. Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, …Viking Therapeutics (VKTX) stock price has silently emerged as one of the best-performing companies in Wall Street this year. It jumped by over 14% on Friday and is up by 1.20% in the pre-market session as investors predict that it could be acquired. The stock has surged by 345% from its lowest point in October and by 94.5% this year.Overview · Interactive Chart · Company Vitals. XNAS: VKTX. 0.00. price (usd). 0.00(0.00%). daily change. 52 week low. 0.00. 52 week high. 0.00. 1Y5Y10YMax.Shares of the clinical-stage biotech Viking Therapeutics (VKTX 13. ... this morning in response to investing firm H.C. Wainwright raising its 12-month price target on the stock from $21 to $33 per ...Jan 26, 2024 · Viking Therapeutics, Inc. (1VT.FRA): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Viking Therapeutics, Inc. | Deutsche Boerse AG ... 5 Feb 2024 ... Viking Therapeutics' stock has rallied ~65% since August, driven by ... About VKTX Stock. Symbol, Last Price, % Chg. VKTX. Viking Therapeutics ...4 days ago · 8 Wall Street research analysts have issued 12-month price targets for Viking Therapeutics' shares. Their VKTX share price targets range from $19.00 to $50.00. On average, they anticipate the company's stock price to reach $34.00 in the next year. This suggests that the stock has a possible downside of 3.8%. The average one-year price target for Viking Therapeutics (NasdaqCM:VKTX) has been revised to 40.12 / share. This is an increase of 15.69% from the prior estimate of 34.68 dated January 16, 2024.An up-and-coming stock with lots of potential is Viking Therapeutics (VKTX-1.27%).Investors have been piling money into the biotech stock this year, as it has surged 150% since January. And at a ...The Viking Therapeutics PE ratio based on its reported earnings over the past 12 months is null.The shares last closed at $18.61.. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors.Why Viking Therapeutics Was Crushing It This Week. A multibillion-dollar deal in the healthcare industry helped lift the stock of a company, Viking Therapeutics (NASDAQ: …Get the latest updates on Viking Therapeutics, Inc. Common Stock (VKTX) after hours trades, after hours share volumes, and more. Make informed investments with Nasdaq.Are you a die-hard fan of the Minnesota Vikings? Do you want to stay updated with every play, touchdown, and victory? Look no further. Fox is the go-to channel for live coverage of...Jul 10, 2023 · Shares of Viking Therapeutics VKTX have surged 63.7% in the year so far against the industry’s 12.0% fall. The upside can be attributed to the successful development of its pipeline candidates ... These 17 analysts have an average price target of $30.71 versus the current price of Viking Therapeutics at $23.8094, implying upside. Below is a summary of how these 17 analysts rated Viking ...Feb 10, 2024 · Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze ... Maxim Group analysts reiterated a buy rating on the stock and raised the price target to $50 from $35, or 79 ... 5 days ago · Viking Therapeutics (VKTX) stock price has silently emerged as one of the best-performing companies in Wall Street this year. It jumped by over 14% on Friday and is up by 1.20% in the pre-market session as investors predict that it could be acquired. The stock has surged by 345% from its lowest point in October and by 94.5% this year. Feb 11, 2024 · Summary of all time highs, changes and price drops for Viking Therapeutics; Historical stock prices; Current Share Price: US$35.74: 52 Week High: US$37.59: 52 Week Low: Mar 30, 2023 · Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ... Jan 29, 2024 · January 29, 2024. Viking Therapeutics, Inc. ( NASDAQ:VKTX - Get Free Report )'s stock price rose 4.7% during trading on Monday . The company traded as high as $22.38 and last traded at $22.38. Approximately 256,407 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 2,502,730 shares. Viking Therapeutics Inc (VKTX) USD0.00001 ; Buy:$36.40 ; Change: $4.35 (13.66%) ; Short code: VKTX ; ISIN: US92686J1060 ; Market cap: $3.64 billion ...2 days ago ... VKTX, Viking Therapeutics, Inc., day gainers, stock prices dynamics, stock of the day.The Viking Therapeutics Inc (VKTX) stock price forecast for the next 12 months is generally negative, with an average analyst price target of $20.39, representing a -42.82% decrease from the current price of …Overview · Interactive Chart · Company Vitals. XNAS: VKTX. 0.00. price (usd). 0.00(0.00%). daily change. 52 week low. 0.00. 52 week high. 0.00. 1Y5Y10YMax.VKTX, Viking Therapeutics, Inc., day gainers, stock prices dynamics, stock of the dayAre you a die-hard fan of the Minnesota Vikings? Do you want to stay updated with every play, touchdown, and victory? Look no further. Fox is the go-to channel for live coverage of...That's the story for Viking Therapeutics ' ( VKTX -0.79%) share price so far this year. The stock jumped nearly 26% year to date by early March. It subsequently gave up all of those gains and then ...Stock analysis for Viking Therapeutics Inc (VKTXW:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.What is the target price for Viking Therapeutics (VKTX) stock? A. The latest price target for Viking Therapeutics ( NASDAQ: VKTX) was reported by Stifel on Wednesday, February 14, 2024. The ...The business’s fifty day moving average price is $23.95 and its 200-day moving average price is $16.74. Viking Therapeutics ... 30,000 shares of Viking Therapeutics stock in a ...Research Viking Therapeutics' (Nasdaq:VKTX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and …Viking Therapeutics Inc. VKTX (U.S.: Nasdaq) Overview Profile FinancialsBased on 5 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $35.75 with a high forecast of $46.00 and a low forecast of $28.00. The average price target represents a 16.91% change from the last price of $30.58. Highest Price Target $46.00. Average Price Target $35.75.President & CEO Brian Lian Sells 269,079 Shares of Viking Therapeutics Inc. (GuruFocus.com) +5.85%. Feb-08-24 04:01PM. Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug. (Investor's Business Daily) +18.01%. Feb 11, 2024 · Get Viking Therapeutics Inc (VKTX.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments The Viking Therapeutics Inc (VKTX) stock price forecast for the next 12 months is generally negative, with an average analyst price target of $20.39, representing a -42.82% decrease from the current price of …Viking Therapeutics, Inc. (VKTX) Stock Price | Stock Quote Nasdaq - MarketScreener VIKING THERAPEUTICS, INC. Add to a list PDF Report Viking …Are you looking for a unique way to explore the world? Look no further than My Viking Cruise. With My Viking Cruise, you can experience the world in a whole new way. My Viking Crui...Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and ... Options; Holders; Sustainability; VKTX - Viking Therapeutics, Inc. NasdaqCM - NasdaqCM Real-time price. Currency in USD. 15.36 +0.16 (+1.05%) At close: 04:00PM EDT. 15.28-0.08 (-0.52%) After hours ...Justin Zelin, an analyst from BTIG, maintained the Buy rating on Viking Therapeutics (VKTX – Research Report). The associated price target is $36.00. Justin …VKTX, Viking Therapeutics, Inc., day gainers, stock prices dynamics, stock of the dayOver the last year, Viking Therapeutics shares have traded in a share price range of $ 8.28 to $ 25.7199. Viking Therapeutics currently has 100,028,953 shares outstanding. The market ... Find the latest Viking Therapeutics, Inc. (1VT.F) stock quote, history, news and other vital information to help you with your stock trading and investing.1.78%. $7.29M. VKTX | Complete Viking Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest dividend history for Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.Are you looking for a unique and unforgettable vacation experience? Look no further than My Viking Cruise. Offering a wide variety of cruise options, My Viking Cruise is the perfec...This price target is based on 8 analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00, with a high forecast of $50.00 and a low forecast of $19.00.Viking Therapeutics moved up its timeline for an Eli Lilly-rivaling obesity treatment on Thursday. VKTX stock rose to a record high. Please watch the video at Investors.com - Biotech Stocks Are ...What is Viking Therapeutics stock price doing today? As of February 13, 2024, VKTX stock price declined to $30.60 with 3,051,971 million shares trading. What is Viking Therapeutics's Beta?Viking Therapeutics moved up its timeline for an Eli Lilly-rivaling obesity treatment on Thursday. VKTX stock rose to a record high. Please watch the video at Investors.com - Biotech Stocks Are ...Viking Therapeutics has a market cap or net worth of $3.19 billion as of February 12, 2024. Its market cap has ... 1-Year Change 352.32%. Ranking # 1572. Category Mid-Cap. Stock Price $31.73. Market Cap Chart $ % Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.19B, an increase of …Viking Therapeutics moved up its timeline for an Eli Lilly-rivaling obesity treatment on Thursday. VKTX stock rose to a record high. Please watch the video at Investors.com - …Historical Price Lookup Stock Calculator News & Events SEC Filings Analyst Coverage Corporate Governance Shareholder Services ... Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders. Contact. General InformationHistorical Price Lookup Stock Calculator News & Events SEC Filings Analyst Coverage Corporate Governance Shareholder Services ... Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders. Contact. General InformationViking's treatment candidate is currently in a Phase 2b clinical trial. The company's stock is down 24.7% so far this year, while the broader S&P 500 has declined 19.1%. Master your money.Over the last year, Viking Therapeutics shares have traded in a share price range of $ 8.28 to $ 25.7199. Viking Therapeutics currently has 100,028,953 shares outstanding. The market ... Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Viking Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! VKTX forecast for the upcoming days Date Price Min Price Max Price; 2024-02-22: Price: 35.669: Min: 33.487: Max: 37.889 ...Financial ratios and metrics for Viking Therapeutics, Inc. (VKTX). Includes annual, quarterly and trailing numbers with full history and charts. ... Stock Analysis Pro. Watchlist. Collapse. Viking Therapeutics, Inc. (VKTX) NASDAQ: VKTX · IEX Real-Time Price · USD. Add to Watchlist 37.03 +0.83 (2.29%) Feb 20, 2024, 10:42 AM EST - …Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...Find the latest Viking Therapeutics, Inc. (1VT.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Feb 17, 2024 · Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of ... Feb 8, 2024 · Viking Therapeutics moved up its timeline for an Eli Lilly ()-rivaling obesity treatment on Thursday.VKTX stock rose to a record high. X. The biotech company is working on two potential weight ... President & CEO Brian Lian Sells 269,079 Shares of Viking Therapeutics Inc. (GuruFocus.com) +5.85%. Feb-08-24 04:01PM. Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug. (Investor's Business Daily) +18.01%. 5 days ago · What is the target price for Viking Therapeutics (VKTX) stock? A. The latest price target for Viking Therapeutics ( NASDAQ: VKTX) was reported by Stifel on Wednesday, February 14, 2024. The ... Get the latest Viking Therapeutics, Inc. (VKTX) stock news and headlines to help you in your trading and investing decisions. VKTX Historical Data ; 02/12/2024, 31.725, 31.340, 31.750, 29.900 ; 02/09/2024, 30.580, 29.370, 32.000, 29.110 ...There are two arguments against buying Viking Therapeutics stock right now, ... Its price-to-book ratio is 17.6, which is dramatically higher than the biotech industry's average of 7.5.Why Viking Therapeutics Was Crushing It This Week. A multibillion-dollar deal in the healthcare industry helped lift the stock of a company, Viking Therapeutics (NASDAQ: …Jul 10, 2023 · Shares of Viking Therapeutics VKTX have surged 63.7% in the year so far against the industry’s 12.0% fall. The upside can be attributed to the successful development of its pipeline candidates ... 5 days ago ... VKTX stock price forecast ... Viking Therapeutics' share price has been in a strong uptrend in the past few months. It has flipped the important ...Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...1.78%. $7.29M. VKTX | Complete Viking Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.What happened. Viking Therapeutics ' ( VKTX -1.18%) shares were down by 9.9% on heavy volume as of 11:14 a.m. ET on Monday. This sizable drop was due to Pfizer 's (NYSE: PFE) announcement that it ...Detailed statistics for Viking Therapeutics, Inc. (VKTX) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Viking Therapeutics, Inc. (VKTX) stock, including valuation metrics, financial numbers, share information and more. ... The stock price has increased by +186.33% in the last …Feb 14, 2024 · According to the current price, Viking Therapeutics is 389.51% away from the 52-week low. What was the 52-week high for Viking Therapeutics stock? The high in the last 52 weeks of Viking ...
Viking Therapeutics, Inc. (VKTX) NasdaqCM - NasdaqCM Real-time price. Currency in USD. Add to watchlist. 36.20 +4.35 (+13.66%) At close: 04:00PM EST. 36.38 +0.18 …. Bat price
Jan 26, 2024 · Viking Therapeutics, Inc. (1VT.FRA): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Viking Therapeutics, Inc. | Deutsche Boerse AG ... The founder of the trillion-dollar chip manufacturer worked as a busboy at Denny’s, graduated high school at 16, and got the Nvidia logo tattooed on his shoulder when the stock price hit $100 ...Feb 16, 2024 · According to the issued ratings of 8 analysts in the last year, the consensus rating for Viking Therapeutics stock is Buy based on the current 8 buy ratings for VKTX. The average twelve-month price prediction for Viking Therapeutics is $34.00 with a high price target of $50.00 and a low price target of $19.00. Are you ready to embark on a journey of discovery and adventure? With the help of MyVikingJourney.com, you can do just that. This online platform provides users with the tools and ...Viking Therapeutics - Stock Quote Stock Information NASDAQVKTX $33.35 NASDAQVKTX Open $31.44 Change $2.75 (8.97%) Day's Range $31.06 - $33.96 52 …The Viking Therapeutics, Inc. stock price is currently $ 32.23 with a total market cap valuation of $ 3.24B ( 100.49M shares outstanding). The Viking Therapeutics, Inc. is trading on NASDAQ with the sign VKTX. Viking Therapeutics, Inc. price is up 5.33% in the past 24 hours. The Viking Therapeutics, Inc. stock price prediction is currently bullish.Stock split history for Viking Therapeutics since 2015. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.Viking Therapeutics, Inc. Common Stock (VKTX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.8 Jun 2023 ... Stock price history for Viking Therapeutics.What is Viking Therapeutics stock price doing today? As of February 13, 2024, VKTX stock price declined to $30.60 with 3,051,971 million shares trading. What is Viking Therapeutics's Beta?Viking Therapeutics Stock Earnings. The value each VKTX share was expected to gain vs. the value that each VKTX share actually gained. Viking Therapeutics ( VKTX) reported Q4 2023 earnings per share (EPS) of -$0.25, meeting estimates of -$0.25 by 3.24%. In the same quarter last year, Viking Therapeutics 's earnings per share (EPS) was -$0.26.Viking Therapeutics (NASDAQ:VKTX) shares gained over 5% in extended trading on Monday after the drugmaker reported positive findings from an ongoing study of its lead drug candidate, VK2809.VK2809 ...Overview · Interactive Chart · Company Vitals. XNAS: VKTX. 0.00. price (usd). 0.00(0.00%). daily change. 52 week low. 0.00. 52 week high. 0.00. 1Y5Y10YMax.The 11 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 33, with a low estimate of 19 and a high estimate of 50. The …The great news at Madrigal This has led us to the stock's current value of $6.99, though it is on another upswing. Viking Therapeutics stock skyrocketed to a new 52-week high and blew past its 52 ...Company profile for Viking Therapeutics, Inc. (VKTX) with a description, list of executives, ... Stock Analysis Pro. Watchlist. Collapse. Viking Therapeutics, Inc. (VKTX) NASDAQ: VKTX · IEX Real-Time Price · USD. Add to Watchlist 34.90-0.84 (-2.35%) Feb 21, 2024, 1:13 PM EST - Market open. Overview; Financials; Statistics; Forecast;Latest Viking Therapeutics Inc (VKTX:NAQ) share price with interactive charts, historical prices, comparative analysis, ... STU Stuttgart Stock Exchange; 1VT:FRA Frankfurt Stock Exchange; ... Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for ….